ascendis pharma glp-1 receptor agonists weight management diabetes treatments Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon - Longstreet Clinic Center for GLP-1 Receptor Agonists as Treatments

For self-funded employers, this reinforces a critical point: this isnt a one-time strategy decisionits a moving target

J Thorac Oncol (2006) 1(1):79

Josefskrankenhaus, Heidenheim Arztpraxis Allgemeinmedizin, Heilbronn Innere Klinik, Herford Innere Med I, Herne Evanangelisches Krankenhaus Innere, Hildesheim GmbH Innere, Idar Oberstein Schwerpunktpraxis, Jena diabetologische Schwerpunktpraxis, Kamen Klinikum Westfalen Hellmig Krankenhaus, Kamen MKK Medizinisches Kompetenzkollegium, Karlsburg Klinik fr Diabetes und Stoffwechsel, Karlsruhe Schwerpunktpraxis, Kirchheim-Nrtingen Innere, Koblenz Kemperhof 1

The overall discontinuation rate due to side effects was around 10% [7]